Towards Global Access & Equity for mRNA Technology: An Update from Afrigen Biologics
Time: 11:15 am
day: Day 2 Track 2 AM
Details:
- Unlocking mRNA vaccine design, development and production geared to enable LMICs to produce mRNA products
- Establishing a “green fields” mRNA end to end commercial production process
- Product innovations for effective, affordable and accessible mRNA vaccines for neglected diseases suitable for LMICs and relevance to pandemic preparedness
